Annual total expenses:
$537.49M+$143.56M(+36.44%)Summary
- As of today (July 4, 2025), RXRX annual total expenses is $537.49 million, with the most recent change of +$143.56 million (+36.44%) on December 31, 2024.
- During the last 3 years, RXRX annual total expenses has risen by +$344.72 million (+178.82%).
- RXRX annual total expenses is now at all-time high.
Performance
RXRX Total expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly total expenses:
$206.19M+$17.91M(+9.51%)Summary
- As of today (July 4, 2025), RXRX quarterly total expenses is $206.19 million, with the most recent change of +$17.91 million (+9.51%) on March 31, 2025.
- Over the past year, RXRX quarterly total expenses has increased by +$96.36 million (+87.73%).
- RXRX quarterly total expenses is now at all-time high.
Performance
RXRX Quarterly total expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Total expenses Formula
Total Expenses = Cost of Goods Sold + Operating Expenses + Non Operating Expenses
RXRX Total expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +36.4% | +87.7% |
| 3 y3 years | +178.8% | +236.5% |
| 5 y5 years | +737.8% | +1024.1% |
RXRX Total expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +178.8% | at high | +179.2% |
| 5 y | 5-year | at high | +737.8% | at high | +1031.8% |
| alltime | all time | at high | +737.8% | at high | +1031.8% |
RXRX Total expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | - | $206.19M(+9.5%) |
| Dec 2024 | $537.49M(+36.4%) | $188.28M(+51.3%) |
| Sep 2024 | - | $124.44M(+8.3%) |
| Jun 2024 | - | $114.95M(+4.7%) |
| Mar 2024 | - | $109.83M(+0.3%) |
| Dec 2023 | $393.94M(+38.0%) | $109.55M(-0.1%) |
| Sep 2023 | - | $109.65M(+18.2%) |
| Jun 2023 | - | $92.73M(+13.1%) |
| Mar 2023 | - | $82.00M(+9.8%) |
| Dec 2022 | $285.41M | $74.66M(-1.3%) |
| Sep 2022 | - | $75.63M(+2.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2022 | - | $73.84M(+20.5%) |
| Mar 2022 | - | $61.28M(-9.2%) |
| Dec 2021 | $192.78M(+119.0%) | $67.46M(+37.9%) |
| Sep 2021 | - | $48.90M(+12.6%) |
| Jun 2021 | - | $43.43M(+31.7%) |
| Mar 2021 | - | $32.98M(+17.2%) |
| Dec 2020 | $88.03M(+37.2%) | - |
| Dec 2020 | - | $28.13M(+20.6%) |
| Sep 2020 | - | $23.34M(+28.1%) |
| Jun 2020 | - | $18.22M(-0.7%) |
| Mar 2020 | - | $18.34M |
| Dec 2019 | $64.15M | - |
FAQ
- What is Recursion Pharmaceuticals annual total expenses?
- What is the all time high annual total expenses for Recursion Pharmaceuticals?
- What is Recursion Pharmaceuticals annual total expenses year-on-year change?
- What is Recursion Pharmaceuticals quarterly total expenses?
- What is the all time high quarterly total expenses for Recursion Pharmaceuticals?
- What is Recursion Pharmaceuticals quarterly total expenses year-on-year change?
What is Recursion Pharmaceuticals annual total expenses?
The current annual total expenses of RXRX is $537.49M
What is the all time high annual total expenses for Recursion Pharmaceuticals?
Recursion Pharmaceuticals all-time high annual total expenses is $537.49M
What is Recursion Pharmaceuticals annual total expenses year-on-year change?
Over the past year, RXRX annual total expenses has changed by +$143.56M (+36.44%)
What is Recursion Pharmaceuticals quarterly total expenses?
The current quarterly total expenses of RXRX is $206.19M
What is the all time high quarterly total expenses for Recursion Pharmaceuticals?
Recursion Pharmaceuticals all-time high quarterly total expenses is $206.19M
What is Recursion Pharmaceuticals quarterly total expenses year-on-year change?
Over the past year, RXRX quarterly total expenses has changed by +$96.36M (+87.73%)